In Vitro Characterization of Nasal Spray to Asses Bioequivalence

  • Dilip Kumar. Cheekti Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.
  • P.V. Tarun Kumar Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.
  • Ramrao Dhage Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India
  • Shambulin Gappa Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.
  • Bikash Sahoo Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Abstract

To layout the characterization of Nasal sprays and discuss the characterization method and sampling plan to assess the in -vitro bioequivalence of test product and reference product. The in -vitro bioequivalence study of nasal sprays are useful to understand the efficiency of test product in comparison to innovator so that the equivalency in the in -vivo studies can be assessed.


The in -vitro bio equivalency characterization of nasal sprays helps us to correlate the efficiency of test product with respect to the reference product, so that the efficacy and safety can be achieved in par with Reference listed drug.


The characterization studies include the product behavior throughout the unit life cycle. The nasal spray test includes the SAC, Priming, repriming, Spray pattern, plume geometry, Droplet size distribution and Drug in small particles.


 

Keywords: SAC, Priming and repriming, Spray pattern, plume geometry, Droplet size distribution and Drug in small particles.

Downloads

Download data is not yet available.

Author Biographies

Dilip Kumar. Cheekti, Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

P.V. Tarun Kumar, Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Ramrao Dhage, Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India

Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India

Shambulin Gappa, Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Bikash Sahoo, Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

Orbicular Pharmaceutical Technologies Pvt Ltd, R&D Center, Plot No: 53, ALEAP Industrial Estate, Behind Pragati Nagar Colony, Kukatpally, Hyderabad – Telangana, India.

References

1. Bioequivalence for nasal sprays importance of device performance -on drug delivery copy right 2016 published Fredrick Furness publishing ltd. 18th April 2016,
2. https://www.ondrugdelivery.com/bioequivalence-nasal-sprays-importance-device-performance
3. Dayal P, Shaik MS, Singh M. Evaluation of different parameters that affect of droplet size distribution from nasal spray using the Malvern spray tec. Journal of pharma science 2014;93(7):1725-42
4. Vitthal Kulkarni and Charles shaw, Formulation characterization of nasal sprays. inhalation June 2012:10-5
5. Suman j. In-Vitro nasal spray characterization. inhalation 2009:15-19
6. FDA- Contains Nonbinding Recommendations Draft Guidance on Mometasone Furoate Monohydrate Recommended Sep 2015, Revised Feb 2019, jun 2020 Contains.
7. FDA - Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation-US FDA guidance document- July 2002.
8. FDA- Product specific guidance contains Nonbinding recommendation Draft guidance on fluticasone propionate, Recommended Sept 2015; Revised Feb 2019
Statistics
87 Views | 102 Downloads
How to Cite
Cheekti, D., Kumar, P., Dhage, R., Gappa, S., & Sahoo, B. ( ). In Vitro Characterization of Nasal Spray to Asses Bioequivalence. Asian Journal of Pharmaceutical Research and Development, 9(6), 84-89. https://doi.org/https://doi.org/10.22270/ajprd.v9i6.1050